Category Archives: Obesity Management

The GlobalWeight Loss and Obesity Management Market,by Product & Services (Drugs, Supplements, Equipment, and Services), by Age Group (Children, Adults, and Geriatric), and by Region(North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued atUS$ 170.0billion in 2019, and is expected to exhibit a CAGR of7.1%over the forecast period (2019-2027),as highlighted in a new report published by Coherent Market Insights. Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/3448 Increasing prevalence of obesity is expected to drive growth of the global weight loss and obesity management market Obesity is defined by excessive body fat and higher body mass index. The average BMI index for obesity is above 30 (obese) Continue reading →

Global Obesity Management Market: Overview Obesity refers to complicated health condition that involves increased body fats levels. Continue reading →

CMIhas added a new report titled Global Weight Loss and Obesity Management Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. Continue reading →

Lifestyle intervention Lifestyle intervention is the fundamental and, currently, the sole treatment of NAFLD, as long as no drugs are approved by regulatory agencies. The favorable effects of weight loss on surrogate biomarkers and imaging tests have been extensively demonstrated in observational studies, but only a few RCTs are available and very few are based on histological outcomes. An exhaustive analysis of this evidence is outside the scope of this article, and several comprehensive reviews are available.108109110111 Calorie restriction and physical activity are consistently recommended in guidelines (table 1) Continue reading →

SAN CLEMENTE, CA / ACCESSWIRE / January 20, 2021 / ReShape Lifesciences Inc. (OTCQB:RSLS), a global weight-loss solutions leader, announced today that it has entered into a definitive merger agreement with Obalon Therapeutics, Inc., which is listed on the NASDAQ Capital Market, a company focused on developing and commercializing novel technologies for weight loss, under which ReShape and Obalon will combine in an all-stock transaction. Continue reading →

Sean Johnson was camping at Duck Creek Village in southern Utah, when he lay down to sleep on the cot he'd recently purchased. That 2013 summer, six-foot-five Sean weighed 650 pounds and the cot was supposed to support 700 pounds of body weight. Instead it broke and he burst into tears Continue reading →

Introduction In both developed and developing countries, pediatric obesity and type 2 diabetes are an increasing public health concern: globally 5.6% of girls and 7.8% of boys aged 5 years have obesity.1 The worldwide incidence of child and adolescent obesity is increasing with an estimated 158 million affected in 2020 and 254 million by 2030.2 Population-based epidemiological data for type 2 diabetes in children and adolescents are limited, but largely indicate increasing incidence rates in developed countries in recent decades.3,4 In the SEARCH for diabetes in youth study, the US type 2 diabetes incidence increased from 9.0 per 100,000 in 20022003 to 13.8 in 20142015 in youth aged 1019 years, which equates to an annual percentage change of 4.8%.5 Incidence of type 2 diabetes is disproportionately higher in youth from certain at-risk groups, including ethnic/racial minorities and those from disadvantaged backgrounds.69 Increasing rates of type 2 diabetes in young people is especially concerning given the earlier onset of related complications and mortality in those with younger compared with older onset of type 2 diabetes.9,10 The increasing prevalence of obesity and type 2 diabetes and the poor prognosis of type 2 diabetes in young people pose significant clinical challenges that require effective treatment strategies. Clinical practice guidelines describe weight loss as a primary goal in the treatment of pediatric obesity in the presence of comorbidities, severe obesity and type 2 diabetes.11,12 It is recommended that weight loss be achieved using a lifestyle modification program that incorporates nutrition and physical activity education, encouraging sustained behavior change.11,13 In type 2 diabetes, once metabolic stability is achieved, lifestyle intervention with metformin therapy is recommended as first-line treatment.12,14,15 Systematic reviews of pediatric obesity treatment demonstrate that conventional lifestyle modification programs lead to modest weight loss in the short-to-medium term.1618 However, many youth with obesity do not respond to conventional treatment,19,20 and, similarly, many youth with type 2 diabetes do not respond to traditional diabetes therapy Continue reading →

BALTIMORE (WJZ) The New Year is traditionally a time when people start to try living a new healthy lifestyle. In the middle of a pandemic, doctors say thats more important than ever Continue reading →

Overweight and obesity refers to excess body fat, and it is related with increased weight-for-height. Continue reading →

TOPEKA As 2021 begins, the Kansas Department of Health and Environment (KDHE) offers 10 healthy habits to begin or to continue this new year! Move more, sit less. Go for a walk, run, bike ride or try a new online fitness video this new year. Incorporating physical activity into your daily routine can lift your spirits, make you feel better and provide some helpful structure to your days. Continue reading →